Correlation Between RAPT Therapeutics and Pmv Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both RAPT Therapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAPT Therapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RAPT Therapeutics and Pmv Pharmaceuticals, you can compare the effects of market volatilities on RAPT Therapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAPT Therapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAPT Therapeutics and Pmv Pharmaceuticals.

Diversification Opportunities for RAPT Therapeutics and Pmv Pharmaceuticals

-0.01

Correlation Coefficient

RAPT Therapeutics  Pmv Pharmaceuticals

Good diversification

The 3 months correlation between RAPT and Pmv is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding RAPT Therapeutics and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and RAPT Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAPT Therapeutics are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of RAPT Therapeutics i.e., RAPT Therapeutics and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between RAPT Therapeutics and Pmv Pharmaceuticals

Given the investment horizon of 90 days RAPT Therapeutics is expected to under-perform the Pmv Pharmaceuticals. In addition to that, RAPT Therapeutics is 2.21 times more volatile than Pmv Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest  249.00  in Pmv Pharmaceuticals on September 15, 2024 and sell it today you would lose (91.00) from holding Pmv Pharmaceuticals or give up 36.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

RAPT Therapeutics  vs.  Pmv Pharmaceuticals

RAPT Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RAPT Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pmv Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Pmv Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with RAPT Therapeutics and Pmv Pharmaceuticals

The main advantage of trading using opposite RAPT Therapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAPT Therapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.

The idea behind RAPT Therapeutics and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.